Brief: Pharnext announces findings evaluating Charcot-Marie-Tooth Neuropathy Score
02/02/2017 07:03
Feb 2 (Reuters) - Pharnext Sas PHARN.PA :
* Pharnext announces findings evaluating Charcot-Marie-Tooth
Neuropathy Score
Source text for Eikon: ID:nBwjQmFKa
Further company coverage: PHARN.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Pharnext SCA
See all newsBrief: Pharnext Progresses On Charcot-Marie-Tooth Disease Study
Brief: Pharnext Reports Topline Results From Pivotal Phase III Clinical Trial Of PXT3003 In Charcot-Marie-Tooth Disease Type 1A
Brief: Pharnext Receives Offer Valuing Its Drug Candidate For Charcotmarie-Tooth Disease At Over Eur 500 Mln
Brief: Pharnext Appoints Dr Gilbert Wagener As Chief Medical Officer
Brief: Pharnext Reports Significant Progress In Search For Pharmaceutical Partners To Finance Its Development